• 1. Synthesis of crown ethers based on a spiro acetal framework
  Margaret A. Brimble,Andrew D. Johnston J. Chem. Soc. Perkin Trans. 1 1998 265
• 2. Syntheses of novel types of calix[6]bis-crowns and related compounds
  Yuanyin Chen,Haibing Li New J. Chem. 2001 25 340
• 3. Syntheses of novel types of calix[6]bis-crowns and related compounds
  Yuanyin Chen,Haibing Li New J. Chem. 2001 25 340
• 4. Anion and cation binding by a pendant arm cyclam and its macrobicyclic derivatives
  Asif Channa,Jonathan W. Steed Dalton Trans. 2005 2455
• 5. Synthesis, complexation properties and spectroscopic studies of the cation-induced conformational changes of some new oligooxaethylene-spacered diporphyrin arrays
  Laura La Monica,Donato Monti,Giovanna Mancini,Marco Montalti,Luca Prodi,Nelsi Zaccheroni,Giuseppe D'Arcangelo,Roberto Paolesse New J. Chem. 2001 25 597

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonic acids and derivatives Benzenesulfonate esters
• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Catalysts and Inorganic Chemicals Inorganic Compounds Salt

Comprehensive Overview of Bis-Tos-PEG4 (CAS No. 37860-51-8): Applications and Innovations in Bioconjugation

Bis-Tos-PEG4 (CAS No. 37860-51-8) is a specialized polyethylene glycol (PEG)-based crosslinker widely utilized in bioconjugation, drug delivery, and materials science. Its unique structure, featuring two tosyl (Tos) groups connected by a tetraethylene glycol (PEG4) spacer, enables efficient bridging between biomolecules, nanoparticles, and polymers. This article explores its properties, applications, and relevance to cutting-edge research trends such as ADC (Antibody-Drug Conjugate) development, nanomedicine, and sustainable chemistry.

The growing demand for PEGylation reagents like Bis-Tos-PEG4 stems from their ability to enhance solubility, stability, and biocompatibility of therapeutic compounds. Researchers frequently search for "PEG4 crosslinker alternatives" or "tosyl-PEG applications," reflecting the need for versatile tools in bioconjugation. With a molecular weight of ~452.5 g/mol, this compound offers optimal spacing for linking proteins, peptides, or small molecules while minimizing steric hindrance—a critical factor in targeted drug delivery systems.

Recent advancements highlight Bis-Tos-PEG4's role in proteomics and diagnostic assay development. Its tosyl groups react selectively with thiols (-SH) or amines (-NH2), enabling controlled conjugation under mild conditions. This aligns with the industry’s shift toward "click chemistry-compatible linkers" and "low-toxicity bioconjugation"—topics dominating academic forums and patent filings. Notably, its water-soluble PEG backbone addresses challenges in biopharmaceutical formulation, a hot topic in FDA-approved drug design.

From an SEO perspective, queries like "how to store Bis-Tos-PEG4" or "Bis-Tos-PEG4 vs. NHS-PEG4" indicate user interest in practical handling and comparative performance. Proper storage at -20°C under inert atmosphere ensures stability, while its non-hygroscopic nature simplifies laboratory workflows compared to ester-based alternatives. The compound’s adaptability to SPDP (N-succinimidyl 3-(2-pyridyldithio)propionate) conjugation protocols further enhances its utility in cancer research and immunotherapy.

Innovations in green chemistry have also spotlighted Bis-Tos-PEG4’s potential. Unlike traditional crosslinkers, its PEG spacer reduces metabolic toxicity—a key concern in "biodegradable PEG derivatives" research. Studies leveraging this reagent for enzyme immobilization or biosensor fabrication demonstrate its compatibility with sustainable biomanufacturing principles. Additionally, its use in mRNA vaccine stabilization (a post-pandemic focus area) underscores its multidisciplinary value.

For researchers exploring "custom PEG linker synthesis," Bis-Tos-PEG4 serves as a modular building block. The tosyl groups can be further modified for orthogonal conjugation strategies, aligning with trends in multi-functional nanocarriers. Its commercial availability from major suppliers (often listed under "PEGylation reagents catalog") ensures accessibility, though purity (>95% by HPLC) remains a critical selection criterion for GMP-grade applications.

In summary, Bis-Tos-PEG4 (CAS 37860-51-8) bridges fundamental chemistry and translational medicine. Its dual functionality, combined with PEG’s proven safety profile, positions it as a cornerstone in next-generation biotherapeutics. As search trends evolve toward "PEG linker optimization" and "site-specific conjugation," this compound continues to inspire innovations across biomaterials science and precision medicine.

• 19249-03-7(Triethylene glycol bis(p-toluenesulfonate))
• 62921-75-9(2-(2-(2-Ethoxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate)
• 50586-80-6(m-PEG2-Tos)
• 62921-74-8(2-(2-(2-Methoxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate)
• 57436-38-1(Octaethylene glycol di(p-toluenesulfonate))
• 41024-91-3(Pentaethylene glycol di(p-toluenesulfonate))
• 7460-82-4(Diethylene Glycol Bis(p-toluenesulfonate))
• 17178-11-9(2-Ethoxyethyl 4-methylbenzenesulfonate)
• 54176-27-1(2-(2-ethoxyethoxy)ethyl 4-methylbenzene-1-sulfonate)
• 62921-76-0(2,5,8,11-Tetraoxatridecan-13-YL 4-methylbenzenesulfonate)